EP1302196A1 - Dentifrice pour promouvoir l'intelligence - Google Patents

Dentifrice pour promouvoir l'intelligence Download PDF

Info

Publication number
EP1302196A1
EP1302196A1 EP02450235A EP02450235A EP1302196A1 EP 1302196 A1 EP1302196 A1 EP 1302196A1 EP 02450235 A EP02450235 A EP 02450235A EP 02450235 A EP02450235 A EP 02450235A EP 1302196 A1 EP1302196 A1 EP 1302196A1
Authority
EP
European Patent Office
Prior art keywords
phosphatidylserine
mouthwash
intelligence
tooth
oral care
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02450235A
Other languages
German (de)
English (en)
Inventor
René Ing. Habinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1302196A1 publication Critical patent/EP1302196A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • vitamins e.g. A, B1, B5, B6, C, E, Certainly be added. These vitamins are absorbed by the body and also regularly needed.
  • the invention relates to oral and dental care products , inter alia in the form of all preparations suitable for oral care, such as toothpastes, tooth gels, tooth powder, mouthwash, mouth bath concentrates, mouthwash or chewing gum, with the intelligence-promoting additive phosphatidylserine (PS for short) and other cell metabolism-stimulating additives , such as for example taurine, ginseng, guarana, lecithin, choline, caffeine, amino acid, selenium, glutamine (acid), nicotinamide, adenine and / or dinucleotide.
  • PS phosphatidylserine
  • other cell metabolism-stimulating additives such as for example taurine, ginseng, guarana, lecithin, choline, caffeine, amino acid, selenium, glutamine (acid), nicotinamide, adenine and / or dinucleotide.
  • Phosphatidylserine for example, has been the subject of intensive research in the past 25 years. It Like lecithin, it is a naturally occurring phospholipid and is also used in small quantities produced by the body. Phosphatidylserine is an important regulator of normal, healthy action of the neurotransmitters and the exchange of information between the Brain cells (neurons).
  • the object of the present invention is to make available a dentifrice with the addition of phosphatidylserine which , with regular use, can lead to a significant improvement in the ability to learn, memory, concentration and accessibility of memory contents.
  • phosphatidylserine Regardless of age and health, everyone can benefit from phosphatidylserine. In pupils with learning difficulties, significant improvements in school performance were found after treatment with phosphatidylserine. It is important to mention that the use of phosphatidylserine has shown no side effects.
  • Phosphatidylserine is also ideal for strength athletes because it does not affect the normal cortisone level in the body, but only prevents an increase in cortisone during physical stressful situations.
  • Phosphatidylserine is used to treat depression and / or deteriorated mental function.
  • phosphatidylserine improves the depressive symptoms and memory of the patient.
  • phosphatidylserine leads to an improvement in depression without showing negative side effects.
  • Phosphatidylserine acts as a therapeutic against the age-related breakdown of nerve cells (dentrites) in the brain. Particularly in the case of older people with age-related memory disorders, very good results for improving learning ability, memory performance, ability to concentrate and accessibility of memory content were achieved.
  • phosphatidylserine has a positive effect on Alzheimer's patients.
  • phosphatidylserine leads to a significant improvement in anxiety symptoms, drive, memory and cognitive skills in Alzheimer's patients .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP02450235A 2001-10-16 2002-10-16 Dentifrice pour promouvoir l'intelligence Withdrawn EP1302196A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT16412001 2001-10-16
AT16412001 2001-10-16

Publications (1)

Publication Number Publication Date
EP1302196A1 true EP1302196A1 (fr) 2003-04-16

Family

ID=3688523

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02450235A Withdrawn EP1302196A1 (fr) 2001-10-16 2002-10-16 Dentifrice pour promouvoir l'intelligence

Country Status (1)

Country Link
EP (1) EP1302196A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2505283C1 (ru) * 2012-08-16 2014-01-27 Общество с ограниченной ответственностью Концерн "КАЛИНА" Композиция зубной пасты
EP3050567A1 (fr) * 2013-09-26 2016-08-03 Energenesis Biomedical Co., Ltd. Composé servant à l'activation de l'ampk et ses utilisations
US10086009B2 (en) 2005-05-23 2018-10-02 Massachusetts Institute Of Technologies Compositions containing pufa and/or uridine and methods of use thereof
CN114191329A (zh) * 2021-12-17 2022-03-18 百瑞全球有限公司 口腔护理添加剂、口腔护理组合物、制备方法、成套用具及其应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651408A (en) * 1979-10-01 1981-05-09 Sunstar Inc Toothpaste composition
CH676324A5 (en) * 1988-09-23 1991-01-15 Pentapharm Ag Haemostatic dentifrice compsns. - contain phospholipid and amphoteric surfactant
DE4117629A1 (de) * 1991-05-29 1992-12-03 Max Planck Gesellschaft Phospatidylserine
WO2000025793A1 (fr) * 1998-10-30 2000-05-11 Merck Patent Gmbh Composition de traitement et de prevention de troubles neurologiques et psychopathologiques
DE19943198A1 (de) * 1999-09-09 2001-03-15 Meyer Lucas Gmbh & Co Therapeutikum zur Behebung zentralnervöser Funktionsstörungen
WO2001026642A2 (fr) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Procedes et compositions pour le traitement de troubles de comportement neurologique

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651408A (en) * 1979-10-01 1981-05-09 Sunstar Inc Toothpaste composition
CH676324A5 (en) * 1988-09-23 1991-01-15 Pentapharm Ag Haemostatic dentifrice compsns. - contain phospholipid and amphoteric surfactant
DE4117629A1 (de) * 1991-05-29 1992-12-03 Max Planck Gesellschaft Phospatidylserine
WO2000025793A1 (fr) * 1998-10-30 2000-05-11 Merck Patent Gmbh Composition de traitement et de prevention de troubles neurologiques et psychopathologiques
DE19943198A1 (de) * 1999-09-09 2001-03-15 Meyer Lucas Gmbh & Co Therapeutikum zur Behebung zentralnervöser Funktionsstörungen
WO2001026642A2 (fr) * 1999-10-08 2001-04-19 Joyce Corinne Bechthold Procedes et compositions pour le traitement de troubles de comportement neurologique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 198126, Derwent World Patents Index; Class A96, AN 1981-46631D, XP002228177 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086009B2 (en) 2005-05-23 2018-10-02 Massachusetts Institute Of Technologies Compositions containing pufa and/or uridine and methods of use thereof
US10525071B2 (en) 2005-05-23 2020-01-07 Massachusets Institue Of Technology Compositions containing PUFA and methods of use thereof
US10736912B2 (en) 2005-05-23 2020-08-11 Massachusetts Institute Of Technology Compositions containing PUFA and/or uridine and methods of use thereof
RU2505283C1 (ru) * 2012-08-16 2014-01-27 Общество с ограниченной ответственностью Концерн "КАЛИНА" Композиция зубной пасты
EP3050567A1 (fr) * 2013-09-26 2016-08-03 Energenesis Biomedical Co., Ltd. Composé servant à l'activation de l'ampk et ses utilisations
EP3050567A4 (fr) * 2013-09-26 2017-04-05 Energenesis Biomedical Co., Ltd. Composé servant à l'activation de l'ampk et ses utilisations
EP3769766A1 (fr) * 2013-09-26 2021-01-27 Energenesis Biomedical Co., Ltd. Adenine pour activer ampk et ses utilisations médicales
CN114191329A (zh) * 2021-12-17 2022-03-18 百瑞全球有限公司 口腔护理添加剂、口腔护理组合物、制备方法、成套用具及其应用
WO2023108866A1 (fr) * 2021-12-17 2023-06-22 百瑞全球有限公司 Additif pour soins buccaux, composition de soins buccaux, procédé de préparation, kit et application d'additif pour soins buccaux

Similar Documents

Publication Publication Date Title
Livingston et al. Diphenylhydantoin gingival hyperplasia
Walsh et al. Clinical effects of pulsed oral irrigation with 0.2% chlorehexidine digluconate in patients with adult periodontitis
DE60217356T2 (de) Creme zur behandlung von sonnengeschädigter haut
DE102017005168A1 (de) Zubereitung zur Anwendung in der Mundhöhle
DE3882135T2 (de) Verwendung von melatonin oder seine derivate zur herstellung von arzneimitteln, die gegen alterskrankheiten wirksam sind.
EP1435971B1 (fr) Utilisation de phosphatidylserine pour traiter le syndrome d'hyperactivite avec deficit d'attention (adhs)
DE69834047T2 (de) Verwendung einer Zubereitung und ein kosmetisches Verfahren zur Verminderung und Vorbeugung von beissender der Haut
EP1302196A1 (fr) Dentifrice pour promouvoir l'intelligence
DE10062770A1 (de) Verwendung von Antioxidantien für Mittel zur Bekämpfung von Mundgeruch
EP2192891B1 (fr) Composition pour produit d'hygiène buccale
US7550488B2 (en) Application methods to rapidly alter disease and injury states using molecular transport of B6
Singh et al. Effect of yoga on dental care: Pranayama techniques or rhythmic breathing exercises on the oral hygiene and gingival bleeding
AT6312U1 (de) Intelligenzfördernde zahncreme
DE68909304T2 (de) Aminosäuren für der Behandung neurodegenerativer Störungen.
DE2642768C2 (fr)
DE202016007098U1 (de) Creme mit Spirulina-Algen
US20060280695A1 (en) Methods and compositions for the prevention, suppression and elimination of oral pain
DE69712287T2 (de) Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden
KR20060110600A (ko) 은나노 용액을 포함하는 탈모치료용 약제학적 조성물
Nividita Puri Holistic approach of oil pulling in the dental world A literature review
Afvari et al. Reply to “Vitamin D status in scarring and nonscarring alopecia”
CN113440424B (zh) 一种可同时护理牙齿和牙龈的牙贴及其制备方法
JP2013144651A (ja) ケラチン産生促進剤、食品、皮膚外用剤及び育毛剤
Popa et al. Antagonic-stress superiority versus meclofenoxate in gerontopsychiatry (alzheimer type dementia)
BR102017014312A2 (pt) composição de base cosmética minimalista biocompatível com pele sensível, uso da composição cosmética e método para evitar sintomas associados à pele sensível

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

AKX Designation fees paid
REG Reference to a national code

Ref country code: DE

Ref legal event code: 8566

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031017